VYCOR MEDICAL INC (VYCO) › Cash & EquivalentsVYCOR MEDICAL INC (VYCO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $12.8K2010: $127.1K2011: $950.8K2012: $59.8K2013: $31.3K2014: $1.89M2015: $347.5K2016: $56.9K2017: $206.2K2018: $86.5K2019: $60.7K2020: $46.0K2021: $90.9K2022: $37.0K2023: $57.3K2024: $105.6K2025: $87.0K$87.0K2009Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$87.0K-17.7%2024$105.6K+84.4%2023$57.3K+54.7%2022$37.0K-59.3%2021$90.9K+97.7%2020$46.0K-24.2%2019$60.7K-29.8%2018$86.5K-58.1%2017$206.2K+262.7%2016$56.9K-83.6%2015$347.5K-81.6%2014$1.89M+5943.1%2013$31.3K-47.7%2012$59.8K-93.7%2011$950.8K+648.2%2010$127.1K+895.1%2009$12.8K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share